A revamped North American trade deal is nearing passage in Congress, giving both the White House and House Democrats cause to claim victory.
A revamped North American trade deal is nearing passage in Congress, giving both the White House and House Democrats cause to claim victory.
It was a reminder, too, that President Donald Trump repeatedly pledged to work to lower drug prices.
“The announcement made today puts politics over patients,” the leading drug industry trade group, PhRMA, said in a statement last week.
When it reached a deal with House Democrats on the USMCA last week, the biologics provision was out.